Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs in Refractory Rheumatoid Arthritis
NCT03333681Phase 1Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2016
- Primary completion
- Aug 2018
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label, single-arm trial of mesenchymal stem cells in rheumatoid arthritis (RA), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Percentage of regulatory T cells at 6 months. Started Jun 2016; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03333681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333681.